The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Is a Potent Inhibitor of ATM- and DNA-PKCs-Mediated DNA Damage Responses

Inhibitors of PI3K/Akt signaling are being actively developed for tumor therapy owing to the frequent mutational activation of the PI3K-Akt-mTORC1 pathway in many cancers, including glioblastomas (GBMs). NVP-BEZ235 is a novel and potent dual PI3K/mTOR inhibitor that is currently in phase 1/2 clinica...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Mukherjee, Bipasha, Tomimatsu, Nozomi, Amancherla, Kaushik, Camacho, Cristel V, Pichamoorthy, Nandini, Burma, Sandeep
פורמט: Artigo
שפה:Inglês
יצא לאור: Neoplasia Press Inc. 2012
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3281940/
https://ncbi.nlm.nih.gov/pubmed/22355272
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים